VENDOR PROFILE · AI SCRIBES · CLOUD
Nabla
A Paris-founded ambient AI copilot used by 85,000 clinicians across 130+ healthcare organizations, with the strongest peer-reviewed evidence base in the category — a UCLA-led randomized clinical trial published in NEJM AI — and the most data-minimal default privacy posture among cloud scribes. The reference for buyers who want rigor and conservative data handling without giving up time-to-value.
Live across 130+ healthcare organizations: academic medical centers, safety-net hospitals, community health centers, and physician groups. Notable customers include CVS Health, Children's Hospital Los Angeles, Carle Health, Denver Health, and University of Iowa Health Care.
Statistically significant reduction in time-on-notes vs. usual care in the UCLA NEJM AI three-arm randomized trial of 238 physicians (Nov 2024 – Jan 2025). Microsoft DAX in the same study did not reach significance.
No audio stored by default. 14-day medical data retention default. No training on customer data. The most data-minimal default settings in the cloud-scribe market.
Led by HV Capital in June 2025, with Highland Europe, DST Global, Cathay Innovation, and Tony Fadell's Build Collective. Total raised: $120M.
What Nabla actually does
Nabla — sometimes shipped as "Nabla Copilot" — is an ambient AI clinician assistant. The clinician opens the copilot, starts a recording, and Nabla handles transcription, speaker separation, and structured note generation in the EHR's expected format. The product surfaces the company is investing in for 2026 are coding, deeper EHR integration, and "agentic" workflows that close out items from the encounter (orders, follow-ups, referrals) rather than just drafting the note.
Real-time transcription and SOAP-format note generation. Customizable templates per specialty and per clinician. 35+ languages supported — the strongest multilingual story in the category.
ICD-10 suggestions in line with the encounter; HCC and CPT coding support being added through 2026. Integrated into the same draft workflow.
Auto-generated plain-language visit summaries the patient can take home. Configurable per organization.
The 2025 Series C narrative shifted Nabla from "ambient scribe" to "agentic AI in clinical workflows." Partnerships such as Navina add longitudinal patient context; the NextGen partnership embeds Nabla as the engine behind NextGen Ambient Assist.
Deployment posture
Cloud-only commercial SaaS, but with the most aggressive data-minimization defaults among the major commercial scribes. The standard configuration does not retain audio, retains structured medical data for 14 days by default, and does not train on customer data. That is not the same as "on-prem" — the inference still happens in Nabla's cloud — but it is the closest a cloud vendor in this category gets to a "least data possible leaves the building" posture.
Joined Epic Toolbox in 2025. Integration via SMART on FHIR — standards-based, not proprietary. Embeds directly inside Epic Haiku on mobile so clinicians don't toggle apps. NextGen Ambient Assist runs on Nabla.
HIPAA + GDPR + ISO 27001 + SOC 2 Type II. Default: no audio storage, 14-day medical data retention, no training on customer data. Confirm the defaults are reflected in the contract before signing.
Epic Toolbox + Haiku as primary surface. Powers NextGen Ambient Assist. Broader EHR coverage than the company's startup size suggests, partly via OEM-style relationships.
Notable: CVS Health, Children's Hospital Los Angeles, Carle Health, Denver Health, University of Iowa Health Care. Dr. Ed Lee, former CIO of The Permanente Federation, is CMO.
The evidence base
Nabla has the strongest published clinical evidence of the commercial scribes profiled in this directory:
- checkUCLA randomized clinical trial (NEJM AI, 2025) — three-arm pragmatic RCT, 238 outpatient physicians, 14 specialties, randomized 1:1:1 to Nabla, Microsoft DAX Copilot, or usual care, November 4, 2024 – January 3, 2025. Nabla physicians saw an estimated 41-second reduction per note (4:30 → 3:49), a statistically significant 9.5% drop versus control. DAX showed a smaller decrease that did not reach statistical significance. Both arms reported ~7% burnout improvement. Trial registry: NCT06792890.
- checkScale evidence — Nabla has now generated more than 8 million AI clinical notes across its customer base. The 85,000-clinician footprint is one of the largest in the category, second only to Abridge.
- closeSafety caveat from the same RCT — UCLA investigators noted that AI-generated notes occasionally contained clinically significant inaccuracies, most often omissions or pronoun errors. One mild patient-safety event was reported during the study window. The signal-to-noise of any ambient scribe still requires clinician review; Nabla's evidence is not an exception to this.
Privacy and compliance posture
Among the major commercial scribes, Nabla has the most defensible privacy posture out of the box. Default settings: no audio storage, 14-day medical data retention, no training on customer data. The compliance stack is wider than U.S.-only peers — HIPAA + GDPR + ISO 27001 + SOC 2 Type II — reflecting the company's European founding and dual-market posture.
The defaults are configurable, which is the right place to focus during contracting. A customer that wants to keep the no-audio-by-default and 14-day-by-default behavior should write those numbers into the contract; a vendor's published defaults can be silently changed if not contractually fixed. For a buyer evaluating Nabla against its peers, this is an unusual dimension on which to be doing the homework — and a real advantage.
That said, Nabla is still a cloud product. Audio is processed off-prem; data is processed off-prem. For Canadian provincial settings under PHIPA, HIA, or Quebec's Law 25 with strict residency interpretations — or any buyer whose binding constraint is "PHI does not leave the building" — Nabla's defaults reduce the surface area but do not eliminate it. The on-prem path is still the cleaner answer for that specific constraint.
Strengths and limitations, plainly
Best peer-reviewed evidence in the category (NEJM AI). Most data-minimal default privacy posture (no audio, 14-day retention, no training on customer data). Strongest multilingual coverage (35+ languages). Wide compliance stack: HIPAA, GDPR, ISO 27001, SOC 2 Type II. OEM relationships (NextGen Ambient Assist) extend the surface beyond direct sales.
Cloud-only. Funding scale is smaller than Abridge or Ambience ($120M total). Coding and CDI surfaces are less mature than Ambience's. The "agentic" 2026 narrative is still unfolding — buyers should evaluate the workflow that exists, not the deck. Default privacy settings need to be locked in contractually to remain durable.
Where Nabla fits versus an on-prem alternative
| Dimension | Nabla (cloud SaaS) | On-prem (WalledCare) |
|---|---|---|
| Evidence rigor | NEJM AI RCT — strongest peer-reviewed evidence in commercial scribe market. | Internal evaluation against the same metrics; no public RCT yet. |
| Privacy default | No audio stored by default; 14-day medical data retention; no training on customer data. | Audio and data never leave the network; retention controlled entirely by the customer. |
| Multilingual | 35+ languages — the strongest in the cloud-scribe category. | Built per customer; relies on Whisper-class models served locally. |
| Compliance stack | HIPAA + GDPR + ISO 27001 + SOC 2 Type II. | Customer-controlled stack; compliance is the customer's posture, not the vendor's. |
| EHR integration | Epic Toolbox + Haiku, SMART on FHIR. Powers NextGen Ambient Assist. | HL7/FHIR + sidecar; tighter for non-Epic EHRs (Oscar, Meditech, custom). |
| Time to first clinician value | Weeks once contracted; OEM channel via NextGen for that ecosystem. | 30–90 days on customer hardware. |
If the framing is "we want the best-evidenced cloud scribe with the cleanest privacy defaults," Nabla is the answer. If the framing is "audio cannot leave our building under any configuration," the on-prem path is still the cleaner one — Nabla's defaults reduce the surface area but do not eliminate it.
Where this fits in the WalledCare directory
Nabla is the strongest commercial reference for the evidence-led framing of AI Scribes. If your team's evaluation rubric weights peer-reviewed RCTs, multilingual coverage, or default privacy posture, Nabla deserves to be on the shortlist alongside Abridge, Ambience, and DeepScribe. If the framing is on-prem residency, read our on-prem reference stack first.
Quick facts
| Founded | 2018, Paris, France. Co-founders: Alexandre Lebrun (CEO), Delphine Groll, Martin Raison. Lebrun previously founded Wit.ai (acquired by Facebook). |
| Leadership | Dr. Ed Lee, CMO — former CIO of The Permanente Federation. |
| Category | AI Scribe / ambient documentation copilot. Coding (ICD-10, HCC, CPT). Patient-facing summaries. Agentic workflow direction. |
| Deployment | Cloud SaaS only. HIPAA + GDPR + ISO 27001 + SOC 2 Type II. BAA. Default: no audio storage, 14-day medical data retention, no training on customer data. |
| Primary EHR | Epic (Toolbox, Haiku, SMART on FHIR). Powers NextGen Ambient Assist. |
| Reference customers | CVS Health, Children's Hospital Los Angeles, Carle Health, Denver Health, University of Iowa Health Care. |
| Coverage | 85,000 clinicians, 130+ healthcare organizations, 55+ specialties, 35+ languages. 8M+ AI clinical notes generated. |
| Evidence | UCLA NEJM AI three-arm RCT (NCT06792890): −9.5% time-on-notes vs. control, statistically significant. ~7% burnout improvement. |
| Funding | $70M Series C June 2025 (HV Capital lead); $24M Series B January 2024. Total $120M raised. |
| Website | nabla.com · Epic integration: nabla.com/epic |
Use Nabla as the benchmark, then decide
If the deciding factor is "strongest published evidence and the most conservative privacy defaults among cloud scribes," Nabla is the shortlist anchor. If the deciding factor is "audio and data cannot leave our network at all," WalledCare's on-prem stack is the alternative built for that.
Further reading
- NEJM AI: Ambient AI Scribes in Clinical Practice — Randomized Trial (UCLA, 2025)
- UCLA Health press release on the randomized trial
- PMC mirror of the UCLA RCT (Ambient AI Scribes in Clinical Practice)
- UCLA Physician Workflow Trial NCT06792890
- PubMed: Randomized trial of two ambient AI scribes
- Nabla $70M Series C announcement
- PR Newswire: Series C — agentic AI for clinical workflows
- Fierce Healthcare: Nabla banks $70M Series C
- Nabla joins Epic Toolbox
- Nabla × Epic integration page
- Nabla Copilot powers NextGen Ambient Assist
- Navina + Nabla partnership for clinical copilot
- Healthcare IT Today: Nabla's 8M AI clinical notes